ClearPoint Neuro (CLPT) FCF Margin (2011 - 2026)
ClearPoint Neuro recorded quarterly FCF Margin of 71.01% in Q1 2026, up 38.93% quarter-over-quarter from 116.27% in Q4 2025, and up 389.0% year-over-year from 14.52% in Q1 2025.
ClearPoint Neuro's FCF Margin history runs 15 years deep, the most recent figure standing at 71.01% for Q1 2026.
- In Q1 2026, FCF Margin rose 389.0% year-over-year to 71.01%; the TTM figure through Mar 2026 stood at 65.69% (down 2927.0% YoY), while the FY2025 annual figure was 66.06%, down 3667.0% from the prior year.
- FCF Margin came in at 71.01% for Q1 2026 at ClearPoint Neuro, up from 116.27% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 14.91% in Q3 2024 to a low of 116.27% in Q4 2025.
- A 5-year average of 59.83% and a median of 59.99% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 5682 bps in 2024 and slumped 9689 bps in 2025, its largest moves.
- ClearPoint Neuro's FCF Margin stood at 59.99% in 2022, then soared by 71 bps to 17.47% in 2023, then decreased by 11 bps to 19.38% in 2024, then plunged by 500 bps to 116.27% in 2025, then surged by 39 bps to 71.01% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 71.01%, 116.27%, and 37.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -71.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.01% |
| Dec 31, 2025 | -116.27% |
| Sep 30, 2025 | -37.47% |
| Jun 30, 2025 | -28.68% |
| Mar 31, 2025 | -74.90% |
| Dec 31, 2024 | -19.38% |
| Sep 30, 2024 | -14.91% |
| Jun 30, 2024 | -33.95% |
| Mar 31, 2024 | -50.27% |
| Dec 31, 2023 | -17.47% |
| Sep 30, 2023 | -35.25% |
| Jun 30, 2023 | -90.72% |
| Mar 31, 2023 | -107.09% |
| Dec 31, 2022 | -59.99% |
| Sep 30, 2022 | -76.20% |
| Jun 30, 2022 | -97.25% |
| Mar 31, 2022 | -86.23% |
| Dec 31, 2021 | -83.84% |
| Sep 30, 2021 | -74.79% |
| Jun 30, 2021 | -107.91% |
| Mar 31, 2021 | -53.87% |
| Dec 31, 2020 | -64.61% |
| Sep 30, 2020 | -38.85% |
| Jun 30, 2020 | -68.93% |
| Mar 31, 2020 | -74.81% |
| Dec 31, 2019 | 6.21% |
| Sep 30, 2019 | -32.93% |
| Jun 30, 2019 | -31.08% |
| Mar 31, 2019 | -24.65% |
| Dec 31, 2018 | -25.62% |
| Sep 30, 2018 | -54.59% |
| Jun 30, 2018 | -69.43% |
| Mar 31, 2018 | -122.05% |
| Mar 31, 2016 | -123.43% |
| Sep 30, 2015 | -137.92% |
| Jun 30, 2015 | -9,978.44% |
| Mar 31, 2015 | -287.21% |
| Dec 31, 2014 | 33,478.44% |
| Sep 30, 2014 | -370.77% |
| Jun 30, 2014 | -149.40% |
| Mar 31, 2014 | -165.53% |
| Dec 31, 2013 | 56.70% |
| Sep 30, 2013 | -6,529.45% |
| Jun 30, 2013 | -449.11% |
| Mar 31, 2013 | -1,462.04% |
| Dec 31, 2012 | -48.69% |
| Sep 30, 2012 | -173.46% |
| Jun 30, 2012 | -1,017.14% |
| Mar 31, 2012 | -1,743.32% |
| Dec 31, 2011 | -320.77% |
| Sep 30, 2011 | -115.89% |
| Jun 30, 2011 | -2,621.63% |
| Mar 31, 2011 | -202.07% |